(Q43496569)

24 November 2017

title

Polymorphisms in cytochromes P450 2C8 and 3A5 are associated with paclitaxel neurotoxicity (English)

1 reference

24 November 2017

1 reference

1 reference

5

1 reference

24 November 2017

Cristina Montero-Conde

9

1 reference

24 November 2017

10

1 reference

24 November 2017

14

1 reference

Cristina Rodríguez-Antona

24 November 2017

15

1 reference

24 November 2017

13

R L Milne

1 reference

24 November 2017

S Leskelä

1

1 reference

24 November 2017

C Jara

2

1 reference

24 November 2017

L J Leandro-García

3

1 reference

24 November 2017

A Martínez

4

1 reference

24 November 2017

S Hernando

6

1 reference

24 November 2017

A Hurtado

7

1 reference

24 November 2017

J C C Vicario

8

1 reference

24 November 2017

E López-Jiménez

11

1 reference

24 November 2017

A Cascón

12

1 reference

24 November 2017

language of work or name

1 reference

9 March 2010

1 reference

The Pharmacogenomics Journal

24 November 2017

published in

1 reference

24 November 2017

volume

11

1 reference

24 November 2017

issue

2

1 reference

24 November 2017

page(s)

121-129

1 reference

https://scigraph.springernature.com/pub.10.1038/tpj.2010.13

24 November 2017

exact match

0 references

cites work

THE DEVELOPMENT AND CLINICAL UTILITY OF THE TAXANE CLASS OF ANTIMICROTUBULE CHEMOTHERAPY AGENTS

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.13

Promotion of microtubule assembly in vitro by taxol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.13

Taxol suppresses dynamics of individual microtubules in living human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.13

Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.13

Peripheral nerve damage associated with administration of taxanes in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.13

Association of Paclitaxel pharmacokinetics with the development of peripheral neuropathy in patients with advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.13

Weekly, high-dose paclitaxel in advanced lung carcinoma: a phase II study with pharmacokinetics by the Cancer and Leukemia Group B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.13

Comparative neurotoxicity of weekly non-break paclitaxel infusions over 1 versus 3 h

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.13

Early predictors of peripheral neurotoxicity in cisplatin and paclitaxel combination chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.13

Pharmacogenetic studies of Paclitaxel in the treatment of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.13

Variants in the SLCO1B3 gene: interethnic distribution and association with paclitaxel pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.13

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.13

Different in vitro metabolism of paclitaxel and docetaxel in humans, rats, pigs, and minipigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.13

Identification of OATP1B3 as a high-affinity hepatocellular transporter of paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.13

Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.13

Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.13

Characterization of novel CYP2C8 haplotypes and their contribution to paclitaxel and repaglinide metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.13

Phenotype-genotype variability in the human CYP3A locus as assessed by the probe drug quinine and analyses of variant CYP3A4 alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.13

ABCB1 genotype and PGP expression, function and therapeutic drug response: a critical review and recommendations for future research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.13

Association of ABCB1 genotypes with paclitaxel-mediated peripheral neuropathy and neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.13

Pharmacogenetic assessment of toxicity and outcome after platinum plus taxane chemotherapy in ovarian cancer: the Scottish Randomised Trial in Ovarian Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.13

Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.13

Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.13

Non-synonymous single nucleotide alterations found in the CYP2C8 gene result in reduced in vitro paclitaxel metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.13

Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.13

Polymorphism in CYP2C8 is associated with reduced plasma concentrations of repaglinide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.13

Impact of genetic polymorphisms in CYP2C8 and rosiglitazone intake on the urinary excretion of dihydroxyeicosatrienoic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.13

Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.13

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.13

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.13

Is advanced age associated with increased incidence and severity of chemotherapy-induced peripheral neuropathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.13

Role of cytochrome P450 2C8 and 2J2 genotypes in calcineurin inhibitor-induced chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.13

Japanese-US common-arm analysis of paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a model for assessing population-related pharmacogenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.13

Taxol impairs anterograde axonal transport of microinjected horseradish peroxidase in dorsal root ganglia neurons in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.13

Compartmentalized microfluidic culture platform to study mechanism of paclitaxel-induced axonal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.13

Randomized Phase III Trial of Weekly Compared With Every-3-Weeks Paclitaxel for Metastatic Breast Cancer, With Trastuzumab for all HER-2 Overexpressors and Random Assignment to Trastuzumab or Not in HER-2 Nonoverexpressors: Final Results of Cancer an

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.13

21 January 2018

Identifiers

DOI

10.1038/TPJ.2010.13

1 reference

Dimensions Publication ID

24 November 2017

1043471117

0 references

1 reference